Registry-listed formulations

This catalogue entry has no confirmed scientific concept.

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

0 source entries across 0 studies. This list may not include all unresolved or historical entries.

    Success Metrics

    Active Trials
    2(67%)

    Phase Distribution

    Phase 2
    1
    33%

    Phase Distribution

    0

    Early Stage

    1

    Mid Stage

    0

    Late Stage

    Phase Distribution1 total trials
    Phase 2Efficacy & side effects
    1(100.0%)

    Highest Phase Reached

    Phase 2

    Trial Status & Enrollment

    Completion Rate

    0.0%

    0 of 0 finished

    Non-Completion Rate

    0.0%

    0 ended early

    Currently Active

    1

    trials recruiting

    Total Trials

    3

    all time

    Status Distribution
    Active(3)

    Detailed Status

    Recruiting1
    Enrolling by invitation1
    Not yet recruiting1

    Development Timeline

    Analytics

    Development Status

    Total Trials
    3
    Active
    2
    Success Rate
    N/A
    Most Advanced
    Phase 2

    Trials by Phase

    Phase 21 (100.0%)

    Trials by Status

    recruiting133%
    enrolling_by_invitation133%
    not_yet_recruiting133%

    Recent Activity

    2 active trials
    Showing 3 of 3
    not_yet_recruitingphase_2

    Prostate Specific Membrane Antigen (PSMA) Imaging for Detection of Residual and Metastatic Prostate Cancer

    NCT07593079
    enrolling_by_invitation

    RegisterPROS - A Registry for Prostate Cancers

    NCT06872619
    recruiting

    A Single-arm, Multicenter Prospective Study to Evaluate the Diagnostic Performance of PROSTest in Men With PSA ≥ 3ng/ml Using Biopsy as the Sole Ground Truth

    NCT07454603

    Clinical Trials (3)

    Showing 3 of 3 trials
    NCT07593079Phase 2

    Prostate Specific Membrane Antigen (PSMA) Imaging for Detection of Residual and Metastatic Prostate Cancer

    Not Yet Recruiting
    NCT06872619

    RegisterPROS - A Registry for Prostate Cancers

    Enrolling By Invitation
    NCT07454603

    A Single-arm, Multicenter Prospective Study to Evaluate the Diagnostic Performance of PROSTest in Men With PSA ≥ 3ng/ml Using Biopsy as the Sole Ground Truth

    Recruiting

    All 3 trials loaded

    Drug Details

    Intervention Type
    Varies by study
    Total Trials
    3